Citation Impact

Citing Papers

Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Angle-closure glaucoma in East Asian and European people. Different diseases?
2005
Determinants of disease and disability in the elderly: The Rotterdam elderly study
1991
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
2014 Standout
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
2016
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea
2010
Ten-Year Incidence and Progression of Age-Related Maculopathy
2006
APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis
2000
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study1 1The authors have no proprietary interest in the products or devices mentioned herein.
2002
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Diabetic retinopathy
2010 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Five-year incidence of age-related maculopathy lesions
2002
The genetics of Parkinson disease: implications for neurological care
2006
The Beaver Dam Eye Study
1992 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
Prevalence of Ocular Disease and Blindness in a Rural Area in the Eastern Region of Iceland during 1980 through 1984
1987
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Age-Related Macular Degeneration
2008 Standout
The prevalence of age-related maculopathy by geographic region and ethnicity1This paper has been edited by Neville N. Osborne, PhD, DSc, Nuffield Laboratory of Ophthalmology, University of Oxford, Walton Street, Oxford, UK; and Gerald J. Chader, The Foundation Fighting Blindness, Hunt Valley, MS.1
1999
Risk Factors for Age-related Macular Degeneration
2001
The role of autophagy in neurodegenerative disease
2013 Standout
Five-year incidence of age-related maculopathy*1The Visual Impairment Project
2004
Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration
2005
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
2008
Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration
2016
Molecular pathogenesis of Parkinson disease: insights from genetic studies
2009
Modeling familial Alzheimer's disease with induced pluripotent stem cells
2011 StandoutNobel
The number of people with glaucoma worldwide in 2010 and 2020
2006 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey
2002
Age and Gender Variations in Age-related Macular Degeneration Prevalence in Populations of European Ancestry: A Meta-analysis
2011
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
2011
The genetics and neuropathology of Parkinson’s disease
2012
Iris color, skin sun sensitivity, and age-related maculopathy
1998
Incidence and Progression of Geographic Atrophy
2013
Prevalence of Age-Related Maculopathy in Older Europeans
2006
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
2007
Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
2003
Regulation of retinal blood flow in health and disease
2008
Do age-related macular degeneration and cardiovascular disease share common antecedents?
1999
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers
2004
Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study
1998
Macular pigment and age related macular degeneration
1999
Primary open-angle glaucoma
2004 Standout
Body Mass Index and the Incidence of Visually Significant Age-Related Maculopathy in Men
2001
Age-related macular degeneration
2012 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
High prevalence of cardiac and extracardiac target organ damage in refractory hypertension
2001
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin–protein ligase with monoubiquitylation capacity
2006
Diabetic Retinopathy
2012 Standout
The Five-year Incidence and Progression of Age-related Maculopathy
1997
Parkinson's disease
2015 Standout
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
2006
HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration
2002
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
2004
Update on the genetics of Parkinson's disease
2007
Mechanisms of mitophagy
2010 Standout
Age-related macular degeneration
2018 Standout
Advances in the genetics of Parkinson disease
2013
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration
2007
The Relationship of Ocular Factors to the Incidence and Progression of Age-Related Maculopathy
1998
Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients
2004
The Relation of Markers of Inflammation and Endothelial Dysfunction to the Prevalence and Progression of Diabetic Retinopathy
2009
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study
2003
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
A Whole-Genome Screen of a Quantitative Trait of Age-Related Maculopathy in Sibships from the Beaver Dam Eye Study
2003
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies
2004
Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
2004
α-synuclein locus duplication as a cause of familial Parkinson's disease
2004 Standout
Vascular endothelial growth factor and diabetic complications
2008
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
2006
Drug-Induced Ocular Disorders
2008
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Risk factors and biomarkers of age-related macular degeneration
2016
Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension
2006
The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme
2007
Genetics of Parkinsonʼs disease
2005
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
Changes in Bruch’s membrane and related structures with age
1999
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Induced Neuronal Cells: How to Make and Define a Neuron
2011 StandoutNobel
Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects
2008
The epidemiology of age-related macular degeneration
2004
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
2010
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
2007
Molecular genetics of macular degeneration
2001
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Intraocular pressure and prevalence of glaucoma in elderly people in Finland: a population-based study
1995
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
2016
Prevalence of Age-related Maculopathy in Australia
1995
Number of people with glaucoma worldwide.
1996 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
2001
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa (TDP‐43) in amyotrophic lateral sclerosis (ALS)
2014
Variants in theAPOEGene Are Associated with Improved Outcome after Anti-VEGF Treatment for Neovascular AMD
2011
Wnt signaling and cancer
2000 Standout
Variations in Primary Open-Angle Glaucoma Prevalence by Age, Gender, and Race: A Bayesian Meta-Analysis
2006
Recent trends in the registration of blindness and partial sight in Leicestershire.
1989
The ageing retina: Physiology or pathology
1987
Cataracts
2017 Standout
Mechanisms of Diabetic Complications
2013 Standout
The Pathophysiology and Treatment of Glaucoma
2014 Standout
The 5-Year Incidence and Risk Factors for Age-Related Maculopathy in a General Japanese Population: The Hisayama Study
2005
The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent.
1994
Diabetic retinopathy management guidelines
2012
Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community
2008
Parkinson's Disease: Genetics and Pathogenesis
2011
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
2010 Standout
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
2005
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 Standout
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction
1997 Standout

Works of Jonathan Gibson being referenced

Seven year follow-up of age-related maculopathy in an elderly British population
1997
Prevalence of age-related maculopathy at two points in time in an elderly British population
1997
Long term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy
1991
Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations
2005
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction
2001
Defining response to anti-VEGF therapies in neovascular AMD
2015
A novel polymorphic triplet repeat in intron five of the α-synuclein gene: no evidence of expansion or allelic association with idiopathic Parkinsonʼs disease in the Irish
2002
USEFULNESS OF OPHTHALMOSCOPY IN MILD TO MODERATE HYPERTENSION
1989
Sorsby's fundus dystrophy: A case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography
1999
Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.
1992
A safety evaluation of ranibizumab in the treatment of age-related macular degeneration
2014
Grading and disease management in national screening for diabetic retinopathy in England and Wales
2003
Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases
2010
Blindness and partial sight in an elderly population.
1986
Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis
1992
A study of the prevalence of eye disease in the elderly in an English community.
1985
Senile cataract and senile macular degeneration: an investigation into possible risk factors.
1986
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
2000
Rankless by CCL
2026